Drug Database
Back to search

Poland· PL-100368783

Acatar Allergy

A azelastine product containing azelastini hydrochloridum, registered in Poland by US Pharmacia Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC R01AC03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAcatar AllergyATCR01AC03REGISTER NO.PL-100368783PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about azelastini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Azelastine is registered in 11 of 19 countries.

Countries holding a registration under ATC R01AC03 (azelastine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search azelastine products by name

Azelastine · ATC R01AC03

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Azelastini hydrochloridum
Manufacturer
US Pharmacia Sp. z o.o.
Country
Poland (PL)
ATC code
R01AC03
ATC class
Azelastine
Defined daily dose
0.56 mg, N
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991360443

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

201 interactions on record for azelastine.

Graded by severity as the source publishes them — 200 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check azelastine against other medicinesHow interaction checks work

Azelastine · interactions on record

201 records

  • 200 moderate
  • 1 minor

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DiphenhydraminA04AB05moderate
  • TriflupromazinA04AD06moderate
  • NabiloneA04AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Azelastine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All azelastine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Allergodil, Allergospray
  • Belgium · Allergodil, Azelergo
  • Bulgaria · Алергодил, Анталерг
  • Czechia · Allergodil, Allergodil Forte
  • Germany · Allergo-Azelind, Allergodil
  • Denmark · Allergodil, Allergodil Forte
  • Estonia · Allergodil
  • Spain · Afluon, Afluón
  • Finland · Lastin
  • France · Allergodil, Alonest
  • United Kingdom (Northern Ireland) · Astepro, Azelair
  • Greece · Afluon
  • Croatia · Vivialle, Vivispray
  • Hungary · Allergodil, Allergodil Forte
  • Ireland · Astepro, Azelastine Eye Drops Mylan Ire Healthcare
  • Iceland · Astepro, Lastin
  • Italy · Allergodil, Allespray
  • Lithuania · Allergodil
  • Luxembourg · Allergodil, Azelergo
  • Latvia · Allergodil
  • Malta · Antalerg Unimed Pharma, Azelastin-Comod
  • Netherlands · Allergodil, Allergodil Nevel
  • Norway · Lastin
  • Portugal · Allergodil, Astepro
  • Romania · Allegodil, Allergodil
  • Sweden · Azelastine Omnivision
  • Slovenia · Alezaxin, Allergodil
  • Slovakia · Allergodil, Antalerg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/315ee7bd-f10c-4ccf-835e-ba1cd3f6a001
GET /v1/drugs/315ee7bd-f10c-4ccf-835e-ba1cd3f6a001?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol do nosa, roztwór",
  "source": "urpl",
  "strength": "1 mg/ml",
  "packaging": "05909991360443 ¦ OTC ¦ 126472\n1 butelka 10 ml",
  "substance": "Azelastini hydrochloridum 1 mg/ml",
  "common_name": "Azelastini hydrochloridum",
  "pl_product_id": "100368783",
  "pozwolenie_nr": "24527",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about azelastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console